Roger Sun
Managing Director>

Focus on Healthcare (Digital Healthcare, Life-science Equipment and Consumables, Biotech)

Roger Sun is a Managing Director of Matrix Partners China. He joined Matrix Partners China in 2016. Roger has led the investment in JYSS Bio-engineering, Naxions, Genecast, Grit Biotechnology, ClouDr Group, Taimei Technology, ExCell Biotech, Inscinstech, GLZHealth, etc.

Prior to Matrix Partners China, Roger had 3 years of experience in healthcare investments, and before that, he worked in Deloitte Shanghai and interned at Roche and CFDA, respectively.

Roger graduated from Fudan University with a Bachelor of Pharmacy.

  • Introduction

    Managing Director
    Shanghai Office

  • Select Investments

    Grit Bio
    ExCell Bio

  • Areas of Interest

    Biotech, Medical devices, Life science equipment and digital health

  • Education

    Bachelor of Pharmacy, Fudan University